⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

March 26, 2024Journal of Dermatological TreatmentOpen Access

Short-term effectiveness and potential factors of ustekinumab based on real-world data in Chinese psoriasis patients

Xingyu Li Xiaowen Xie Jiashuai Li Jingjin Hu Kun Hu Minjia Tan Jing Yang Sichun Deng Yijie Liu Mi Zhang Yehong Kuang Junchen Chen Liqiu Liao Wu Zhu

View Full Paper

Ask AI

Bookmark

Share

Abstract

As one of the most effective biologic treatments for psoriasis, the short-term effectiveness of ustekinumab has yet to be studied extensively.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e7254ab6db64358769f094 https://doi.org/10.1080/09546634.2024.2321188

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Treatment efficacy and patient satisfaction of ustekinumab compared with tumor necrosis factor-alpha inhibitors in Chinese patients with moderate-to-severe psoriasis: a real-world study2024 · 2 citations
2Long-term effectiveness and safety of ustekinumab in patients with Crohn’ s disease: real-world evidence2025 · 4 citations
3Long-Term Effectiveness and Persistence of Ustekinumab in Crohn’s Disease Patients: An Observational Retrospective StudyCohort Study · 2026
4Ustekinumab for the treatment of psoriasis: a well-established therapy primed for resurgenceClinical Trial · 2026
5Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium2024 · 12 citations

More related papers

High persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort study2025
High persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort study2025
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study2022

More from Journal of Dermatological Treatment

Adalimumab durability in hidradenitis suppurativa: persistence is not synonymous with sustained responseSun,
Long-term efficacy of lebrikizumab in treating head, neck and face involvement in patients with moderate-to-severe atopic dermatitisMon,